Why the study?
It was unknown whether increased RAAS activation and endothelin-1 levels are related to CAC score, total plaque volume, high risk plaque, hyperemic MBF, and coronary microvascular dysfunction.
Are increased RAAS activation (renin) and endothelin-1 levels associated with coronary atherosclerotic burden and microvascular dysfunction in patients with suspected CAD?
Are increased RAAS activation (renin) and endothelin-1 levels associated with coronary atherosclerotic burden and microvascular dysfunction in patients with suspected CAD?
RAAS activity, measured by renin concentration, is elevated in patients with coronary atherosclerosis and high-risk plaque, but not in those with coronary microvascular dysfunction.
Answers are grounded in this paper and cite their sources.
May support RAAS and endothelin-1 involvement in plaque and CMD; leaves open causality and clinical relevance.
Background and aims In this study, we investigated whether increased renin angiotensin aldosterone system (RAAS) activation and endothelin-1 levels are related to coronary artery calcium (CAC) score, total plaque volume (TPV), high risk plaque, hyperemic myocardial blood flow (MBF) and coronary microvascular dysfunction (CMD). Methods In a prospective, observational, cross-sectional cohort, renin as a marker for RAAS activation and endothelin-1 were measured in peripheral venous blood of 205 patients (64% men; age 58 ± 8.7 years) with suspected coronary artery disease (CAD) who underwent coronary computed tomography angiography (CCTA), [ 15 O]H 2 O positron emission tomography (PET) perfusion imaging and invasive fractional flow reserve (FFR) measurements. Patients were categorized into three groups based on FFR (≤0.80) and hyperemic MBF <2.3 ml/min/g: [1] obstructive CAD (n = 92), [2] CMD (n = 26) or [3] no or non-obstructive CAD (n = 85). Results After correction for baseline characteristics, including RAAS inhibiting therapy, renin associated positively with CAC score and TPV, but not with hyperemic MBF ( p < 0.01; p = 0.02 and p = 0.23). Patients with high risk plaque displayed higher levels of renin (mean logarithmic renin 1.25 ± 0.43 vs. 1.12 ± 0.35 pg/ml; p = 0.04), but not endothelin-1. Compared to no or non-obstructive CAD patients, renin was significantly elevated in obstructive CAD patients but not in CMD patients (mean logarithmic renin 1.06 ± 0.34 vs. 1.23 ± 0.36; p < 0.01 and 1.06 ± 0.34 vs. 1.16 ± 0.41 pg/ml; p = 0.65). Endothelin-1 did not differ between the three patient groups. Conclusions Our report provides evidence that RAAS activity measured by renin concentration is elevated in patients with coronary atherosclerosis and high risk plaque but not in patients with CMD, whereas endothelin-1 is not related to either.
No takes yet. Share an insight, caveat, or question.
Jukema et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: